港股異動丨阜博集團大升近9%,將參加2025 CES全球消費電子展
阜博集團(3738.HK)走強,盤中一度大升近9%,報3.8港元。消息面上,備受全球矚目的科技盛會——2025 CES全球消費電子展將於1月7日-10日在美國拉斯維加斯舉行。作為全球規模最大、最具權威性及影響力的科技盛會,CES被譽為“科技春晚”,是全球科技創新和消費電子行業的風向標。屆時,來自世界各地的頭部科技玩家將展示最前沿的創新技術和卓越產品,生動詮釋科技賦能生活的無限可能。CES本屆展會的主題重點包含人工智能。據悉,阜博集團將參加在美國拉斯維加斯的CES展會,並展示其在AIGC時代提供的新型解決方案,為創作者提供權利保護,並結合生成式AI的變革力量實現傳媒行業裏新的收入增長。(格隆匯)

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.